Your Cart is Empty

Equivac 2 in 1 1ml Syringe Zoetis

THIS PRODUCT IS NOT AVAILABLE TO PURCHASE ONLINE. Please email or phone us for pricing.

Product Details:

  • Equivac 2 in 1 is used in the prevention of tetanus due to Clostridium tetani and in the control of strangles due to Streptococcus equi subspecies equi in horses.
  • Equivac 2 in 1 is one of a range of Equivac products available for tetanus and strangles treatment and control.

Pack sizes:

  • 1 ml syringe.

Key Features:

  • Equivac 2 in 1 provides a more practical and economical means of vaccinating simultaneously for both tetanus and strangles than purchasing and administering two separate vaccines.
  • Prevention of tetanus: A single dose of Equivac 2 in 1 given to an unimmunised horse at the time of wounding or surgery may not prevent tetanus. For short-term prevention of tetanus, Equivac® TAT should also be used. See entry for Equivac TAT.
  • Combined Active-Passive Protection: Equivac 2 in 1 can be administered simultaneously with Equivac TAT. A separate needle and syringe should be used for each product and administration should be on opposite sides of the body. If initiating a primary course the second dose of Equivac 2 in 1 should be administered 3 to 6 weeks later.


  • See product leaflet for full instructions.
  • 1 mL injected intra-muscularly.
  • For primary immunisation of horses against strangles, horses 3 months of age or older should be given 3 doses of vaccine at intervals no less than 2 weeks apart. For ongoing immunisation, booster doses should be given annually, or every 6 months for horses at higher risk of exposure. Equivac® S may be used for strangles vaccination where tetanus inclusion is not warranted.
  • For primary immunisation of horses against tetanus, horses 3 months of age and older should be given 2 doses at intervals of 4 to 6 weeks, followed by a booster 12 months later. Further boosters for tetanus are recommended by the Equine Infectious Diseases Advisory Board every 12 months for maximal protection against tetanus infection.
  • The product leaflet should be consulted for guidance as to the use of strangles vaccine in the event of an outbreak.
  • It is recommended that strangles vaccination be a component of a herd-health biosecurity-focussed management program for the prevention and control of strangles in horses.


Store between 2°C and 8°C. (Refrigerate. Do not freeze). Protect from light.


Additional human user safety

Take care to avoid accidental self-injection. In the event of self- administration, seek medical attention if you are concerned and show the package leaflet or the label, to the Medical Practitioner.

First Aid Statement

If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131126.

This material may cause a mild allergic reaction in sensitive individuals on skin contact. Avoid skin contact. If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running water. If splashed in eyes, wash out immediately with water.

Registered label warnings

Withholding Periods

Zero (0) days


ESI not applicable

Side Effects

Localised swelling may develop at the site of injection and a firm nodular lump may persist for some weeks or even months. There may be temporary lameness. Allergic reactions such as anaphylaxis occur rarely with all vaccines and may require appropriate treatment.